SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $30,000 | +7.1% | 17,513 | +41.2% | 0.00% | – |
| Q2 2015 | $28,000 | -34.9% | 12,405 | -23.2% | 0.00% | – |
| Q4 2014 | $43,000 | +4.9% | 16,148 | +18.0% | 0.00% | – |
| Q3 2014 | $41,000 | -63.4% | 13,685 | -47.2% | 0.00% | – |
| Q1 2014 | $112,000 | +72.3% | 25,932 | +108.5% | 0.00% | – |
| Q4 2013 | $65,000 | -3.0% | 12,435 | +18.0% | 0.00% | – |
| Q3 2013 | $67,000 | +28.8% | 10,542 | +1.6% | 0.00% | – |
| Q2 2013 | $52,000 | – | 10,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |